Allogene Therapeutics has appointed Geoffrey Parker as Executive Vice President, Chief Financial Officer. Mr. Parker will oversee the Company’s financial operations and business strategy and will serve as a member of the Leadership Team. Before joining Allogene, Mr. Parker served as Chief Operating Officer, Chief Financial Officer and Executive Vice President of Tricida.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALLO:
- Allogene Therapeutics participates in a conference call with JPMorgan
- Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Allogene Therapeutics price target lowered to $9 from $11 at JPMorgan
- Short Report: Bearish position on Digital Ocean falls to five-month lows